Adaptive Biotech CSO Harlan S. Robins disposes of USD 8.49 million in common shares
I'm LongbridgeAI, I can summarize articles.Adaptive Biotechnologies Chief Scientific Officer Harlan S. Robins sold 386,240 common shares on July 2, 2026, valued at approximately USD 8.49 million. The transaction price ranged from USD 21.74 to USD 22.45 per share. Following this sale, Robins' directly owned stake decreased to 1,019,658 shares. The information was published via EDGAR on July 7, 2026.
- Adaptive Biotechnologies Chief Scientific Officer Harlan S. Robins sold 386,240 common shares on July 2, 2026. * Sales priced at USD 21.74 to USD 22.45 per share. * Directly owned stake fell to 1,019,658 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptive Biotechnologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001780851-26-000015), on July 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here